Vit Weinberger

Dr. Vit Weinberger

Department of Obstetrics and Gynecology, University Hospital Brno, Czech Republic, Masaryk University
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in Gynecologic Oncology
Verified
Journal Article
Closed access
MZMichal Zikan
Michal Zikan
DFDaniela Fischerova
Daniela Fischerova
IPIvana Pinkavova
Ivana Pinkavova
JSJiri Slama
Jiri Slama
VWVit Weinberger
Vit Weinberger
DCDavid Cibula
David Cibula

1 January 2021 in European Journal of Cancer
Verified
Journal Article
Closed access
DCDavid Cibula
David Cibula
LDL. Dostalek
L. Dostalek
PHPeter Hillemanns
Peter Hillemanns
GSG. Scambia
G. Scambia
JJJ. Jarkovsky
J. Jarkovsky
IRI. Runnenbaum
I. Runnenbaum

1 March 2021 in Human Pathology
Verified
Journal Article
Closed access
WWWillem Jan Van Weelden
Willem Jan Van Weelden
CRCasper Reijnen
Casper Reijnen
HKHeidi V.N. Küsters-Vandevelde
Heidi V.N. Küsters-Vandevelde
JBJohan Bulten
Johan Bulten
PBPeter Bult
Peter Bult
JPJohanna Pijnenborg
Johanna Pijnenborg

16 October 2021 in European Journal of Cancer
Verified
Journal Article
Closed access
DCDavid Cibula
David Cibula
LDLukáš Dostálek
Lukáš Dostálek
JJJiri Jarkovsky
Jiri Jarkovsky
CMConstantijne H. Mom
Constantijne H. Mom
ALAldo Lopez
Aldo Lopez
LLLuc R.C.W. van Lonkhuijzen
Luc R.C.W. van Lonkhuijzen

17 December 2021 in Cancers
Verified
Journal Article
Open access
PDF file
JHJitka Holčáková
Jitka Holčáková
MBMartin Bartosik
Martin Bartosik
MAMilan Anton
Milan Anton
LMLubos Minar
Lubos Minar
JHJitka Hausnerova
Jitka Hausnerova
RHRoman Hrstka
Roman Hrstka
The prevention and early diagnostics of precancerous stages are key aspects of contemporary oncology. In cervical cancer, well-organized screening and vaccination programs, especially in developed countries, are responsible for the dramatic decline of invasive cancer incidence and mortality. Cytological screening has a long and successful history, and the ongoing implementation of HPV triage with increased sensitivity can further decrease mortality. On the other hand, endometrial and ovarian cancers are characterized by a poor accessibility to specimen collection, which represents a major complication for early diagnostics. Therefore, despite relatively promising data from evaluating the combined effects of genetic variants, population screening does not exist, and the implementation of new biomarkers is, thus, necessary. The introduction of various circulating biomarkers is of potential interest due to the considerable heterogeneity of cancer, as highlighted in this review, which focuses exclusively on the most common tumors of the genital tract, namely, cervical, endometrial, and ovarian cancers. However, it is clearly shown that these malignancies represent different entities that evolve in different ways, and it is therefore necessary to use different methods for their diagnosis and treatment.

4 May 2023 in Cancers
Verified
Journal Article
Open access
PDF file
MLMarike S. Lombaers
Marike S. Lombaers
KCKarlijn Maria Cornelia Cornel
Karlijn Maria Cornelia Cornel
NVNicole C. M. Visser
Nicole C. M. Visser
JBJohan Bulten
Johan Bulten
HKHeidi V. N. Küsters-Vandevelde
Heidi V. N. Küsters-Vandevelde
JPJohanna Pijnenborg
Johanna Pijnenborg
Patients with high-grade endometrial carcinoma (EC) have an increased risk of tumor spread and lymph node metastasis (LNM). Preoperative imaging and CA125 can be used in work-up. As data on cancer antigen 125 (CA125) in high-grade EC are limited, we aimed to study primarily the predictive value of CA125, and secondarily the contributive value of computed tomography (CT) for advanced stage and LNM. Patients with high-grade EC (n = 333) and available preoperative CA125 were included retrospectively. The association of CA125 and CT findings with LNM was analyzed by logistic regression. Elevated CA125 ((>35 U/mL), (35.2% (68/193)) was significantly associated with stage III-IV disease (60.3% (41/68)) compared with normal CA125 (20.8% (26/125), [p < 0.001]), and with reduced disease-specific—(DSS) (p < 0.001) and overall survival (OS) (p < 0.001). The overall accuracy of predicting LNM by CT resulted in an area under the curve (AUC) of 0.623 (p < 0.001) independent of CA125. Stratification by CA125 resulted in an AUC of 0.484 (normal), and 0.660 (elevated). In multivariate analysis elevated CA125, non-endometrioid histology, pathological deep myometrial invasion ≥50%, and cervical involvement were significant predictors of LNM, whereas suspected LNM on CT was not. This shows that elevated CA125 is a relevant independent predictor of advanced stage and outcome specifically in high-grade EC.